AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BioAffinity (BIAF.O) has taken a dramatic hit today, falling more than 21% in intraday trading to trade at levels not seen in months. With no fresh fundamental news to explain the sharp decline, traders are scrambling to understand the trigger. Here's a deep-dive look at what might be behind the sudden selloff.
While most of the key technical patterns such as the head-and-shoulders and double tops did not trigger, the KDJ death cross did activate, signaling a bearish shift in momentum. A death cross in KDJ typically occurs when the K line (fast) crosses below the D line (slow), which is often seen as a sell signal by technical traders. This suggests that short-term traders may have exited the stock, worsening the downward pressure.
Unfortunately, there is no available
trading or cash-flow data to pinpoint where buy or sell orders may have clustered. This absence of real-time liquidity insights makes it harder to determine whether the selloff was driven by large institutional selling or a broad-based retail exodus. In either case, the lack of bids likely exacerbated the price drop.Several related stocks, especially those in the biotech and tech-biotech crossover space, also posted sharp declines. For instance:
These moves suggest that the selloff may not be entirely isolated to BIAF.O, but instead part of a broader thematic rotation out of high-beta small-caps in the life sciences and tech sectors.
Based on the evidence:
With no block trade data, we can’t say for sure whether a large holder liquidated their position. But given the context, the most plausible explanation is a sector-driven selloff accelerated by bearish technical triggers.

Knowing stock market today at a glance

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.19 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet